Patents by Inventor Antara Datta

Antara Datta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ELISA detection of urine DEK to predict and diagnose bladder cancer in humans
    Patent number: 10845365
    Abstract: The present invention is directed to a method of detecting a DEK protein in a human urine sample using an ELISA assay. Methods and compositions for detection of DEK using mAb 260-6F9F6 (as detection antibody) and mAb 16-2C9C3 (as capture antibody) in human urine are provided herein. Specifically, the ELISA assay utilizes a capture mAb and a detection mAb to yield a high sensitivity of <50 ng/mL. The presence of DEK in urine is useful in predicting or diagnosing the occurrence of bladder cancer in humans.
    Type: Grant
    Filed: July 21, 2017
    Date of Patent: November 24, 2020
    Assignee: Medical Diagnostic Laboratories, LLC
    Inventors: Antara Datta, Jason Trama
  • ELISA Detection of Urine DEK to Predict and Diagnose Bladder Cancer in Humans
    Publication number: 20180011097
    Abstract: The present invention is directed to a method of detecting a DEK protein in a human urine sample using an ELISA assay. Methods and compositions for detection of DEK using mAb 260-6F9F6 (as detection antibody) and mAb 16-2C9C3 (as capture antibody) in human urine are provided herein. Specifically, the ELISA assay utilizes a capture mAb and a detection mAb to yield a high sensitivity of <50 ng/mL. The presence of DEK in urine is useful in predicting or diagnosing the occurrence of bladder cancer in humans.
    Type: Application
    Filed: July 21, 2017
    Publication date: January 11, 2018
    Applicant: Medical Diagnostic Laboratories, LLC
    Inventors: Antara Datta, Jason Trama
  • ELISA detection of urine DEK to predict and diagnose bladder cancer in humans
    Patent number: 9746473
    Abstract: The present invention is directed to a method of detecting a DEK protein in a human urine sample using an ELISA assay. Methods and compositions for detection of DEK using mAb 260-6F9F6 (as detection antibody) and mAb 16-2C9C3 (as capture antibody) in human urine are provided herein. Specifically, the ELISA assay utilizes a capture mAb and a detection mAb to yield a high sensitivity of <50 ng/mL. The presence of DEK in urine is useful in predicting or diagnosing the occurrence of bladder cancer in humans.
    Type: Grant
    Filed: November 12, 2015
    Date of Patent: August 29, 2017
    Assignee: Medical Diagnostic Laboratories, LLC
    Inventors: Antara Datta, Jason Trama
  • ELISA Detection of Urine DEK to Predict and Diagnose Bladder Cancer in Humans
    Publication number: 20160116475
    Abstract: The present invention is directed to a method of detecting a DEK protein in a human urine sample using an ELISA assay. Methods and compositions for detection of DEK using mAb 260-6F9F6 (as detection antibody) and mAb 16-2C9C3 (as capture antibody) in human urine are provided herein. Specifically, the ELISA assay utilizes a capture mAb and a detection mAb to yield a high sensitivity of <50 ng/mL. The presence of DEK in urine is useful in predicting or diagnosing the occurrence of bladder cancer in humans.
    Type: Application
    Filed: November 12, 2015
    Publication date: April 28, 2016
    Applicant: MEDICAL DIAGNOSTIC LABORATORIES, LLC
    Inventors: Antara Datta, Jason Trama
  • ELISA detection of urine DEK to predict and diagnose bladder cancer in humans
    Patent number: 9255925
    Abstract: The present invention is directed to a method of detecting a DEK protein in a human urine sample using an ELISA assay. Methods and compositions for detection of DEK using mAb 260-6F9F6 (as detection antibody) and mAb 16-2C9C3 (as capture antibody) in human urine are provided herein. Specifically, the ELISA assay utilizes a capture mAb and a detection mAb to yield a high sensitivity of <50 ng/mL. The presence of DEK in urine is useful in predicting or diagnosing the occurrence of bladder cancer in humans.
    Type: Grant
    Filed: April 22, 2014
    Date of Patent: February 9, 2016
    Assignee: Medical Diagnostic Laboratories, LLC
    Inventors: Antara Datta, Jason Trama
  • ELISA Detection of Urine DEK to Predict and Diagnose Bladder Cancer in Humans
    Publication number: 20140295463
    Abstract: The present invention is directed to a method of detecting a DEK protein in a human urine sample using an ELISA assay. Methods and compositions for detection of DEK using mAb 260-6F9F6 (as detection antibody) and mAb 16-2C9C3 (as capture antibody) in human urine are provided herein. Specifically, the ELISA assay utilizes a capture mAb and a detection mAb to yield a high sensitivity of <50 ng/mL. The presence of DEK in urine is useful in predicting or diagnosing the occurrence of bladder cancer in humans.
    Type: Application
    Filed: April 22, 2014
    Publication date: October 2, 2014
    Applicant: MEDICAL DIAGNOSTIC LABORATORIES, LLC
    Inventors: Antara Datta, Jason Trama
  • Detection of a specific DEK isoform as a urine-based biomarker for bladder cancer
    Patent number: 8741582
    Abstract: The present invention is directed to a method of detecting a DEK protein isoform 2 in a human urine sample using ELISA. Methods and compositions for detection of DEK isoform 2 in human urine are provided herein. The presence of DEK isoform 2 in urine is shown to correlate with bladder cancer in humans.
    Type: Grant
    Filed: October 20, 2011
    Date of Patent: June 3, 2014
    Assignee: Medical Diagnostic Laboratories, LLC
    Inventors: Antara Datta, Jason Trama
  • DEK as a urine based biomarker for bladder cancer
    Patent number: 8658376
    Abstract: The present invention is directed to a method of detecting DEK protein in a urine sample. Methods and compositions are provided herein for detecting and diagnosing bladder cancer by chemical-induced precipitation of urine proteins, followed by filtration-induced concentration and Western blot analysis to specifically detect DEK protein. The present method permits specific detection of DEK protein in urine as a biomarker for bladder cancer in humans.
    Type: Grant
    Filed: October 20, 2011
    Date of Patent: February 25, 2014
    Assignee: Medical Diagnostic Laboratories, LLC
    Inventors: Antara Datta, Jason Trama
  • Detection of a specific DEK isoform as a urine-based biomarker for bladder cancer
    Publication number: 20120196305
    Abstract: The present invention is directed to a method of detecting a DEK protein isoform 2 in a human urine sample using ELISA. Methods and compositions for detection of DEK isoform 2 in human urine are provided herein. The presence of DEK isoform 2 in urine is shown to correlate with bladder cancer in humans.
    Type: Application
    Filed: October 20, 2011
    Publication date: August 2, 2012
    Applicant: Medical Diagnostic Laboratories, LLC
    Inventors: Antara Datta, Jason Trama
  • DEK as a urine based biomarker for bladder cancer
    Publication number: 20120190046
    Abstract: The present invention is directed to a method of detecting DEK protein in a urine sample. Methods and compositions are provided herein for detecting and diagnosing bladder cancer by chemical-induced precipitation of urine proteins, followed by filtration-induced concentration and Western blot analysis to specifically detect DEK protein. The present method permits specific detection of DEK protein in urine as a biomarker for bladder cancer in humans.
    Type: Application
    Filed: October 20, 2011
    Publication date: July 26, 2012
    Applicant: Medical Diagnostic Laboratories, LLC
    Inventors: Antara Datta, Jason Trama